Neumora Therapeutics IPO Presentation Deck
Led by Experienced Company Builders and Leading Neuroscience
Drug Developers
Leadership
Paul Berns
Co-Founder and Executive
Chairman
ARCH
PATSIRS
ALLOS"
ANACOR
Abbott -BASF
We crescit
abbvie
PPD
Bristol Myers Squibb
Joshua Pinto, Ph.D.
Chief Financial Officer
CREDIT SUISSE
Lilly
PIPER SANDLER
Michael Gold, MD
Chief Medical Officer
Lori Houle
Chief Quality Officer
VIR
S
Dermira SAREPTA
Henry Gosebruch
Chief Executive Officer
abbvie J.P.Morgan
ACELYRINA APTINYX
Bill Aurora, Pharm.D.
Chief Strategy Officer
Dermira Neurocrine
MERCK AMGEN
Nick Brandon, Ph.D.
Chief Scientific Officer
MERCK
Jnana
Pfizer AstraZeneca
Raj Manchanda, Ph.D.
Chief Technical Operations
Officer
ANOKION
FREQUENCY
THERAPEUTICS
Biogen
Carol Suh
Chief Operating Officer and
Co-Founder
ORBITAL
ARCH
Sana
BOUNDLESS BIO
Autobahn
Rob Lenz, MD, Ph.D.
Head of Research &
Development
AMGEN Abbott
Mary Chamberlain-
Tharp, Ph.D.
Chief Business Officer
abbvie Lilly
Amy Sullivan
SVP, Human Resources.
sobi Takeda
Shire
Blue Chip Investors
A
ARCH
VENTURE
PARTNERS
ADGVENTURE ADIA
CATALIO
MUBADALA SoftBank Vision Fund
CAPITAL MANAGEMENT
INVUS
AMGENⓇ
ALEXANDRIA.
VENTURE INVESTMENTS
LOGOS
CAPITAL
Exor
ALTITUDE
Life Science Ventures
SURVEYOR
F/PRIME
Newpath polarispartners
Confidential
6View entire presentation